Anuradha Lala-Trindade
NPI 1003076902 · Cardiovascular Disease Physician · New York, NY
Enrolled with Medicare as Practitioner - Cardiovascular Disease (cardiology) · source: CMS PECOS Public Provider Enrollment (2026.04.01)
Provider details
- NPI number
- 1003076902
- Entity type
- Individual
- Primary specialty
- Cardiovascular Disease PhysicianAllopathic & Osteopathic Physicians
- Sex
- Female
- Sole proprietor
- No
Specialties & taxonomies
Allopathic & Osteopathic Physicians
Student, Health Care
Profile Score
A profile completeness & documented-activity index — NOT a quality, outcomes, or patient-satisfaction rating.
- Registry tenure25% of score
18 yrs in NPPES registry
- Profile completeness25% of score
83% of core fields populated
- Practice footprint15% of score
1 documented practice location
- Medicare service volume (vs. specialty peers)25% of score
405 Medicare services, 2024 (ranked within specialty)
- Open Payments transparency10% of score
Has Open Payments disclosures (2024)
Medicare volume is ranked against active providers in the same specialty. Signals a provider has no public data for (e.g. Medicare claims) are left out of the score entirely — never counted as zero — so providers without that data are not penalized. See the full formula and weights in our .
What this provider does (Medicare)
Based on Medicare fee-for-service claims, 2024; not all care is captured.
| Service (HCPCS) | Medicare services | Typical Medicare-allowed (2024) |
|---|---|---|
| Subsequent Hospital Care With Moderate Levelof Medical Decision Making, If Using Time, at Least 50 Minutes99233 | 126 | $129 |
| Established Patient Office Or Other Outpatient Visit With High Level of Medical Decision Making, If Using Time, 40 Minutes Or More99215 | 79 | $156 |
| Routine Electrocardiogram (ecg) Using at Least 12 Leads With Interpretation and Report Only93010 | 67 | $9 |
| Critical Care, First 30-74 Minutes99291 | 45 | $232 |
| Evaluation of Lower Heart Chamber Assist Device93750 | 43 | $44 |
| Established Patient Office Or Other Outpatient Visit With Moderate Level of Decision Making, If Using Time, 30 Minutes Or More99214 |
What this provider prescribes (Medicare Part D)
Top drugs by Medicare Part D claim volume, 2024 · 26 distinct drugs on file.
| Drug | Part D claims (2024) | Beneficiaries |
|---|---|---|
| Rosuvastatin Calcium | 65 | 20 |
| Sacubitril/Valsartanbrand: Entresto | 63 | 13 |
| Dapagliflozin Propanediolbrand: Farxiga | 46 | — |
| Apixabanbrand: Eliquis | 37 | — |
| Carvedilol | 36 | — |
| Metoprolol Succinate | 33 | — |
| Spironolactone |
Transparency — industry payments
Based on CMS Open Payments, 2024; not all care is captured.
$91,696 across 67 records (Open Payments 2024)
Open Payments discloses payments and transfers of value (meals, travel, consulting, research, royalties) from drug and device makers to providers. This is a transparency signal, not a verdict — such payments are legal and common, and their presence is neither an endorsement nor a criticism. Source: CMS Open Payments, program year 2024.
Practice location
Mailing address
Registry dates
- Enumerated
- 2008-06-13
- Last updated
- 2015-03-06
Source: CMS NPPES Data Dissemination (June 2026). NPI Central is not affiliated with CMS. Data is provided as-is from the public registry.